Skip to main content

Table 2 Clinical and cycle characteristics of ovarian stimulation in the groups

From: Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study

Characteristics

Group A (n = 304) (HMG300IU + MPA)

Group B (n = 274) (HMG300IU + MPA + CC)

P

Baseline hormones

 E2 (pg /ml)

54.47 ± 47.82

50.73 ± 43.12

0.291

 FSH (mIU/l)

12.92 ± 9.37

12.98 ± 10.09

0.579

 LH (mIU/ml)

5.95 ± 7.20

6.09 ± 6.82

0.672

Hormones level on the day of HCG

 E2 (pg/ml)

1376.51 ± 926.02

1093.07 ± 786.72

 < 0.001

 LH (mIU/ml)

2.92 ± 2.41

6.66 ± 4.34

 < 0.001

 P (ng/ml)

0.56 ± 0.63

0.93 ± 2.93

0.002

Total HMG doses (IU)

3399.18 ± 820.75

2998.63 ± 1051.09

 < 0.001

HMG duration (days)

11.27 ± 2.56

10.21 ± 3.56

 < 0.001

 > 14 mm follicles on the day of HCG (n)

3.64 ± 2.06

2.75 ± 1.97

 < 0.001

Retrieved oocytes (n)

3.02 ± 2.08

2.30 ± 2.22

 < 0.001

Mature oocytes (n)

2.61 ± 1.93

1.98 ± 2.07

 < 0.001

Fertilized oocytes (n)

1.90 ± 1.58

1.47 ± 1.68

 < 0.001

Viable embryos (n)

1.48 ± 1.33

1.22 ± 1.40

0.019

High-quality embryos (n)

0.69 ± 1.00

0.52 ± 0.78

0.091

Oocyte retrieval rate n (%)

917/1107 (82.84)

631/756 (83.47)

0.722

Mature oocytes rate n (%)

793/917 (86.48)

542/631 (85.90)

0.744

Fertilization rate n (%)

578/793 (72.89)

404/542 (74.54)

0.502

Viable embryos rate n (%)

451/578 (78.03)

333/404 (82.43)

0.091